Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis

Objectives. Adalimumab, etanercept and infliximab are effective TNF inhibitors (TNFis) in the treatment of RA, but no randomized clinical trials have compared the three agents. Prior observational data are not consistent. We compared their effectiveness over 1 year in a prospective cohort. Methods....

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Canhão, Helena, Rodrigues, Ana Maria, Mourão, Ana Filipa, Martins, Fernando, Santos, Maria José, Canas-Silva, José, Polido-Pereira, Joaquim, Pereira Silva, José Alberto, Costa, José António, Araújo, Domingos, Silva, Cândida, Santos, Helena, Duarte, Cátia, da Silva, José Antonio Pereira, Pimentel-Santos, Fernando M., Branco, Jaime Cunha, Karlson, Elizabeth W., Fonseca, João Eurico, Solomon, Daniel H.
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2012
נושאים:
Clinical Science
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3475979/
https://ncbi.nlm.nih.gov/pubmed/22843791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kes184
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים